Impact of cholesterol on disease progression

Chun Jung Lin, Cheng Kuo Lai, Min Chuan Kao, Lii Tzu Wu, U. Ging Lo, Li Chiung Lin, Yu An Chen, Ho Lin, Jer Tsong Hsieh, Chih Ho Lai, Chia Der Lin

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Cholesterol-rich microdomains (also called lipid rafts), where platforms for signaling are provided and thought to be associated with microbe-induced pathogenesis and lead to cancer progression. After treatment of cells with cholesterol disrupting or usurping agents, raft-associated proteins and lipids can be dissociated, and this renders the cell structure nonfunctional and therefore mitigates disease severity. This review focuses on the role of cholesterol in disease progression including cancer development and infectious diseases. Understanding the molecular mechanisms of cholesterol in these diseases may provide insight into the development of novel strategies for controlling these diseases in clinical scenarios.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalBioMedicine (Netherlands)
Volume5
Issue number2
DOIs
StatePublished - Jun 1 2015

Fingerprint

Disease Progression
Cholesterol
Lipids
Communicable Diseases
Neoplasms
Cells
Proteins

Keywords

  • Cancer development
  • Cholesterol
  • HMG-CoA reductase
  • Infectious disease
  • Lipid rafts

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Lin, C. J., Lai, C. K., Kao, M. C., Wu, L. T., Lo, U. G., Lin, L. C., ... Lin, C. D. (2015). Impact of cholesterol on disease progression. BioMedicine (Netherlands), 5(2), 1-7. https://doi.org/10.7603/s40681-015-0007-8

Impact of cholesterol on disease progression. / Lin, Chun Jung; Lai, Cheng Kuo; Kao, Min Chuan; Wu, Lii Tzu; Lo, U. Ging; Lin, Li Chiung; Chen, Yu An; Lin, Ho; Hsieh, Jer Tsong; Lai, Chih Ho; Lin, Chia Der.

In: BioMedicine (Netherlands), Vol. 5, No. 2, 01.06.2015, p. 1-7.

Research output: Contribution to journalArticle

Lin, CJ, Lai, CK, Kao, MC, Wu, LT, Lo, UG, Lin, LC, Chen, YA, Lin, H, Hsieh, JT, Lai, CH & Lin, CD 2015, 'Impact of cholesterol on disease progression', BioMedicine (Netherlands), vol. 5, no. 2, pp. 1-7. https://doi.org/10.7603/s40681-015-0007-8
Lin CJ, Lai CK, Kao MC, Wu LT, Lo UG, Lin LC et al. Impact of cholesterol on disease progression. BioMedicine (Netherlands). 2015 Jun 1;5(2):1-7. https://doi.org/10.7603/s40681-015-0007-8
Lin, Chun Jung ; Lai, Cheng Kuo ; Kao, Min Chuan ; Wu, Lii Tzu ; Lo, U. Ging ; Lin, Li Chiung ; Chen, Yu An ; Lin, Ho ; Hsieh, Jer Tsong ; Lai, Chih Ho ; Lin, Chia Der. / Impact of cholesterol on disease progression. In: BioMedicine (Netherlands). 2015 ; Vol. 5, No. 2. pp. 1-7.
@article{8d2d6c35f0774fdd8efdbe856b6fb721,
title = "Impact of cholesterol on disease progression",
abstract = "Cholesterol-rich microdomains (also called lipid rafts), where platforms for signaling are provided and thought to be associated with microbe-induced pathogenesis and lead to cancer progression. After treatment of cells with cholesterol disrupting or usurping agents, raft-associated proteins and lipids can be dissociated, and this renders the cell structure nonfunctional and therefore mitigates disease severity. This review focuses on the role of cholesterol in disease progression including cancer development and infectious diseases. Understanding the molecular mechanisms of cholesterol in these diseases may provide insight into the development of novel strategies for controlling these diseases in clinical scenarios.",
keywords = "Cancer development, Cholesterol, HMG-CoA reductase, Infectious disease, Lipid rafts",
author = "Lin, {Chun Jung} and Lai, {Cheng Kuo} and Kao, {Min Chuan} and Wu, {Lii Tzu} and Lo, {U. Ging} and Lin, {Li Chiung} and Chen, {Yu An} and Ho Lin and Hsieh, {Jer Tsong} and Lai, {Chih Ho} and Lin, {Chia Der}",
year = "2015",
month = "6",
day = "1",
doi = "10.7603/s40681-015-0007-8",
language = "English (US)",
volume = "5",
pages = "1--7",
journal = "BioMedicine (Netherlands)",
issn = "2211-8020",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Impact of cholesterol on disease progression

AU - Lin, Chun Jung

AU - Lai, Cheng Kuo

AU - Kao, Min Chuan

AU - Wu, Lii Tzu

AU - Lo, U. Ging

AU - Lin, Li Chiung

AU - Chen, Yu An

AU - Lin, Ho

AU - Hsieh, Jer Tsong

AU - Lai, Chih Ho

AU - Lin, Chia Der

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Cholesterol-rich microdomains (also called lipid rafts), where platforms for signaling are provided and thought to be associated with microbe-induced pathogenesis and lead to cancer progression. After treatment of cells with cholesterol disrupting or usurping agents, raft-associated proteins and lipids can be dissociated, and this renders the cell structure nonfunctional and therefore mitigates disease severity. This review focuses on the role of cholesterol in disease progression including cancer development and infectious diseases. Understanding the molecular mechanisms of cholesterol in these diseases may provide insight into the development of novel strategies for controlling these diseases in clinical scenarios.

AB - Cholesterol-rich microdomains (also called lipid rafts), where platforms for signaling are provided and thought to be associated with microbe-induced pathogenesis and lead to cancer progression. After treatment of cells with cholesterol disrupting or usurping agents, raft-associated proteins and lipids can be dissociated, and this renders the cell structure nonfunctional and therefore mitigates disease severity. This review focuses on the role of cholesterol in disease progression including cancer development and infectious diseases. Understanding the molecular mechanisms of cholesterol in these diseases may provide insight into the development of novel strategies for controlling these diseases in clinical scenarios.

KW - Cancer development

KW - Cholesterol

KW - HMG-CoA reductase

KW - Infectious disease

KW - Lipid rafts

UR - http://www.scopus.com/inward/record.url?scp=84939428728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939428728&partnerID=8YFLogxK

U2 - 10.7603/s40681-015-0007-8

DO - 10.7603/s40681-015-0007-8

M3 - Article

VL - 5

SP - 1

EP - 7

JO - BioMedicine (Netherlands)

JF - BioMedicine (Netherlands)

SN - 2211-8020

IS - 2

ER -